Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Phasebio Pharmaceuticals (PHAS) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 7 quarters since 2019. Compare with PHAS stock chart to see long term trends.

PHAS stock compared to

PHAS Income Statement

Revenue, Net:0
Revenue Per Share:0
Research & Development Expense:17416000
Total Operating Expenses:20492000
Operating Income:-20492000
Net Income:-25143000
Earnings Per Share, Basic:-0.86
Shares Outstanding, Basic Avg:29364824

PHAS Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:55000
Net Cash from Operations:-15827000
Issuance of Long-term Debt:0
Net Cash from Financing Activities:2333000
Property, Plant & Equipment Purchases:178000
Net Cash from Investing Activities:-178000
Net Change in Cash & Equivalents:-13672000

PHAS Balance Sheet

Cash and Cash Equivalents:39353000
Total Current Assets:49948000
Property, Plant & Equipment, Net:6164000
Total Assets:58207000
Accounts Payable:2124000
Current Portion of Long-Term Debt:5341000
Total Short-Term Liabilities:11370000
Long Term Debt, Non-Current Portion:8117000
Total Liabilities:53855000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Wellington Management Group Llp
3,329,262 sh
-686,967 sh
-17%
$11,686
-$6,788
Blackrock Inc.
1,134,939 sh
52,770 sh
5%
$3,984
-$993
Vanguard Group Inc
728,678 sh
-9,175 sh
-1%
$2,557
-$837
Stifel Financial Corp
187,837 sh
10,651 sh
6%
$659
-$156
Northern Trust Corp
166,939 sh
316 sh
0%
$586
-$180
Bridgeway Capital Management Inc
152,600 sh
 
$536
Morgan Stanley
101,650 sh
-60,026 sh
-37%
$356
-$387
Sabby Management, LLC
79,470 sh
2,500 sh
3%
$279
-$75
Charles Schwab Investment Management Inc
40,648 sh
 
$143
California State Teachers Retirement System
21,999 sh
629 sh
3%
$77
-$21
Goldman Sachs Group Inc
13,906 sh
-14,611 sh
-51%
$49
-$82
Bank Of America Corp /De/
5,667 sh
-1,504 sh
-21%
$20
-$13
Royal Bank Of Canada
2,023 sh
-108 sh
-5%
$7
-$3
Legal & General Group Plc
1,919 sh
-850 sh
-31%
$7
-$6
Ameritas Investment Partners, Inc.
1,211 sh
 
$4
Panagora Asset Management Inc
612 sh
612 sh
NEW
$2
$2
Price T Rowe Associates Inc /Md/
0 sh
-535,315 sh
-100%
$0
-$2,462
Renaissance Technologies LLC
0 sh
-131,500 sh
-100%
$0
-$605
Ameriprise Financial Inc
0 sh
-88,346 sh
-100%
$0
-$406
Proequities, Inc.
0 sh
 
$0

Data imported from Phasebio Pharmaceuticals Inc SEC filings. Check original filings before making any investment decision.